In this proposal for competitive renewal of award RO1-NS-27321, there are two broad goals: (a) define the lymphocyte surface molecules responsible for permitting T-lymphoblasts rapid entry into the CNS (and other sites); and (b) characterize the changes occurring in areas of the CNS which are rendered susceptible to inflammation.
These aims are established based upon observations made under the present award. Two of these observations are: (a) T-cells readily enter the CNS regardless of MHC compatibility, antigen specificity, or phenotype if they are in the lymphoblast phase - resting/memory cells are excluded; and (b) a site specific model of Wallerian degeneration will alter a specific site in the CNS from be inflammation resistant to being inflammation susceptible within 24 hours. In reaching the stated goals, many convergent avenues of investigation of both T-cell membrane antigens and tissue molecular changes will be used. These will include both in vivo and in vitro studies. The methods to be employed are: in situ hybridization, monoclonal antibody production, T-cell tissue culture, FACS analysis, and in vivo systems of cytokine infusion, experimental allergic encephalomyelitis, Wallerian degeneration, Graft vs. Host disease, and T-lymphoblast transfer. The results of these studies should be readily applicable to any human illness in which the CNS is damaged by inflammation mediated by T-cells. Examples of such diseases are multiple sclerosis, viral encephalitis and post vaccinial encephalomyelitis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS027321-07
Application #
2266370
Study Section
Neurology C Study Section (NEUC)
Project Start
1988-09-01
Project End
1996-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Pathology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Williams, Kenneth C; Hickey, William F (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537-62
Sweitzer, Sarah M; Hickey, William F; Rutkowski, Maria D et al. (2002) Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain 100:163-70
Kielian, Tammy; van Rooijen, Nico; Hickey, William F (2002) MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J Neurooncol 56:1-12
Kielian, T; Barry, B; Hickey, W F (2001) CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol 166:4634-43
Hickey, W F (2001) Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118-24
Ratcliffe, N R; Wegmann, K W; Zhao, R W et al. (2000) Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells. J Autoimmun 15:369-79
Ratcliffe, N R; Hutchins, J; Barry, B et al. (2000) Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis. J Autoimmun 15:359-67
Yeager, M P; DeLeo, J A; Hoopes, P J et al. (2000) Trauma and inflammation modulate lymphocyte localization in vivo: quantitation of tissue entry and retention using indium-111-labeled lymphocytes. Crit Care Med 28:1477-82
Kielian, T; Hickey, W F (2000) Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol 157:647-58
Williams, K C; Zhao, W; Politopoulou, G et al. (2000) Inhibition of experimental allergic encephalomyelitis with an antibody that recognizes a novel antigen expressed on lymphocytes, endothelial cells, and microglia. Lab Invest 80:313-26

Showing the most recent 10 out of 57 publications